Navigation Links
New CoMotion(R) Trials Software by General Dynamics Enables Rapid, Interactive Sharing of Real-time Data for Clinical Trials
Date:4/28/2008

Software enables clinical-trial researchers, analysts and managers to visualize and collaborate across the room or around the world, in real-time

SCOTTSDALE, Ariz., April 28 /PRNewswire/ -- General Dynamics Viz, a part of General Dynamics C4 Systems, introduces CoMotion(R) Trials, a collaborative, decision-support software tool that enables hundreds of researchers, analysts and managers to see, analyze, share and comment on data and information produced throughout the clinical trials process. The software, which runs on a commercial off-the-shelf computer, integrates data from many separate systems, portraying it in easily configurable charts and visualizations.

Required by the U.S. government, clinical trials comprise rigorous research, testing and analysis of the safety and effectiveness of new pharmaceuticals and medical equipment. A clinical trial can last several years and involve measurement and analysis of information from thousands of patients in hospitals, clinics or other medical facilities located worldwide. As more trials adopt computer-based systems to capture electronic data, the volume and complexity of information increases. As a result, software-based tools are needed to streamline the organization, interpretation and decision-making responsibilities that clinical trials teams must complete.

"With this software, clinical trials stakeholders don't have to stitch emails, wikis and sticky-notes together for the big-picture view of what's happening during a clinical trial," said Mike Capsambelis, product management director for General Dynamics Viz. "CoMotion Trials streamlines the flow of information during every phase of the clinical trials process, and that means significant cost and time savings for everyone involved."

CoMotion Trials is built on General Dynamics' CoMotion(R) software technology, currently used in the life sciences industry and by the U.S. government and military. For the military, CoMotion is part of an established battle management system that enables commanders and their staffs to collaboratively develop operational plans, then monitor plan rehearsal and execution from geographically dispersed headquarters.

General Dynamics C4 Systems, a business unit of General Dynamics (NYSE: GD), is a leading integrator of secure communication and information systems and technology.

General Dynamics, headquartered in Falls Church, Va., employs approximately 83,500 people worldwide and reported 2007 revenues of $27.2 billion. The company is a market leader in business aviation; land and expeditionary combat systems, armaments and munitions; shipbuilding and marine systems; and information systems and technologies. More information about the company is available on the Internet at http://www.generaldynamics.com.


'/>"/>
SOURCE General Dynamics C4 Systems
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
3. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
4. Multiple NIH Phase 2 HIV Vaccine Trials Using Vicals Technology Produce Encouraging Results
5. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
6. Sunesis Pharmaceuticals Commences Clinical Trials of SNS-595 and SNS-314
7. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
8. Biodel Inc. Expands Ongoing Phase III VIAject(TM) Clinical Trials Into Europe
9. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
10. Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease
11. BiPar Expands Management Team to Advance Lead PARP Inhibitor Product Candidate Into Phase 2 Trials for Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... , April 19, 2017  IRIDEX Corporation (Nasdaq: ... financial results for the first quarter 2017 after the ... Company,s management team will host a corresponding conference call ... Investors interested in listening to the conference ... domestic callers or (703) 326-3030 for international callers, using ...
(Date:4/19/2017)... April 19, 2017 Global Prostate Cancer ... on the prostate cancer therapeutics market analyzes the ... Increasing prevalence of prostate cancer, launch of promising ... development of new drugs & therapeutic biological products, ... due to lesser side effects are some of ...
(Date:4/19/2017)... -- The Global Effective Microorganisms (EM) Market by ... covered and analysed the potential of Global Effective Microorganisms (EM) ... and growth factors. The report identifies and analyses the emerging ... global market. ... Tables and Figures, 6 Major Company Profiles, spread across 124 ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... 2017 , ... Accreditation Commission for Health Care (ACHC) is ... (HCAOA). This agreement allows HCAOA members to receive special pricing on ACHC’s Home ... University (AU) educational resources that help prepare HCAOA members for ACHC Accreditation. , ...
(Date:4/28/2017)... ... ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced today that ... as “stable.” At the same time, the ratings agency cautioned that the company’s rating ... “capital adequacy” thresholds required for its strong rating. , “Horizon is committed to being ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... tubes . These lamps offer an instant energy-saving solution for F32T8 fluorescent lamps ... fixtures or disconnect ballasts. These 50,000 hour rated lamps utilize the existing electronic ...
(Date:4/28/2017)... ... ... The Texas Cord Blood Bank (TCBB), a program of nonprofit biomedical organization GenCure, ... at Renaissance in Edinburg for their outstanding efforts in collecting umbilical cord blood donations ... , “Women’s Hospital at Renaissance has been a collection partner for the TCBB since ...
(Date:4/28/2017)... Ca (PRWEB) , ... April 28, 2017 , ... Bill ... management industry in the coastal communities. After Tina Howe joined the team, the Bill ... happy employees, honest services at affordable rates, and giving back to the San Diego ...
Breaking Medicine News(10 mins):